News


May 11, 2015


SAN DIEGO, April 30, 2015 /PRNewswire/ — Tamir Biotechnology, a leading developer of RNA modulating drugs, announced today an update on its Ebola antiviral therapy program.

Read the full article here.
From prnewswire.com

Back to top